MPT

Medical Properties Trust is downgraded to a sell due to persistent tenant issues, high leverage, and unsustainable dividend risk. MPT's recent $2.4B refinancing extends maturities but raises interest costs to 9.25%, squeezing already thin earnings and coverage ratios. A dividend yield of 10.3% appears attractive, but cash-adjusted FFO and asset sales suggest the payout is not well-supported and risk remains elevated.

Medical Properties Trust demonstrates real-world asset value with $680 million in Q3 cash proceeds from hospital and Infracore sales. Recent hospital sales achieved 60–72% gains over original investments, supporting MPT's ability to monetize assets above book value. Proceeds are earmarked for debt reduction, improving leverage and partially offsetting FFO/AFFO headwinds from higher refinancing rates.

Medical Properties Trust stock continued its strong downward this week, reaching its lowest level since January 13 last year. MPT dropped to $3.40, down by over 32% this year and by 83% in the last five years.

Medical Properties Trust remains fundamentally challenged, with high debt, rising funding costs, and persistent cash burn undermining sustainability. Recent distressed debt exchange refinanced $2.4 billion, easing short-term liquidity but pushing a $6.3 billion debt wall to 2032 at a 9.25% rate. Interest expenses are set to consume 55-57% of 2027 revenue, with ongoing negative cash flow and unsustainable dividends funded by additional debt.

Medical Properties Trust is upgraded to a cautious, speculative Buy as refinancing risk is materially reduced without equity issuance. MPW trades at ~0.48x book value, with recent asset sales above carrying value and a significantly extended debt maturity profile. The rent ramp thesis is supported by embedded lease escalations, with HSA and NOR expected to normalize rent payments to 100% by year-end.

Medical Properties Trust's $2.4 billion financing package pushes major debt maturities out to 2032—eliminating immediate refinancing risk at the expense of higher interest costs. A clear look at the $0.057 per share quarterly FFO headwind from the new 9.25% Senior Notes and how upcoming rent ramp-ups aim to cushion the impact. The $1.1 billion asset sale pipeline is achieving prices substantially higher than original cost bases.

BIRMINGHAM, Ala.--(BUSINESS WIRE)--MPT (the “Company” or “MPT”) (NYSE: MPT) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.09 per share of common stock to be paid on October 8, 2026, to stockholders of record on September 10, 2026. About Medical Properties Trust, Inc. Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Al.

Medical Properties Trust remains a 'strong buy' despite recent share price declines and investor frustration over debt refinancing. Revenue growth, driven by successful retenanting and acquisitions, outpaced analyst expectations, while cash flow and adjusted FFO metrics improved year-over-year. MPW's debt refinancing increases interest expense but reduces net debt and extends maturities, with book value per share decline slowing significantly.

Medical Properties Trust NYSE: MPT said it has launched a two-step refinancing plan intended to address its 2026 and 2027 debt maturities, while reporting second-quarter normalized funds from operations of $0.15 per share and describing stable performance across much of its hospital portfolio.

Medical Properties (MPT) came out with quarterly funds from operations (FFO) of $0.15 per share, missing the Zacks Consensus Estimate of $0.16 per share. This compares to FFO of $0.14 per share a year ago.